| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | 0% | $561,702 | +$35,627 | 1,478,164 | +6.8% | Mitchell P. Kopin | 31 Dec 2025 |
| Anson Funds Management LP | 4.9% | -33% | $265,805 | -$96,100 | 699,486 | -27% | Anson Funds Management LP | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC | 0.84% | -84% | $30,375 | -$153,500 | 37,500 | -83% | Renaissance Technologies LLC | 31 Dec 2024 |
As of 31 Dec 2025, 14 institutional investors reported holding 1,195,221 shares of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO). This represents 8.4% of the company’s total 14,275,224 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,195,221 | $406,372 | -$428,125 | $0.34 | 14 |
| 2025 Q3 | 1,551,022 | $1,069,833 | +$795,693 | $0.69 | 14 |
| 2025 Q2 | 406,814 | $256,292 | +$89,070 | $0.63 | 13 |
| 2025 Q1 | 247,864 | $285,030 | +$101,430 | $1.17 | 12 |
| 2024 Q4 | 182,551 | $161,999 | -$141,059 | $0.89 | 14 |
| 2024 Q3 | 337,799 | $371,282 | +$242,634 | $1.10 | 12 |
| 2024 Q2 | 119,574 | $117,878 | +$5,461 | $1.00 | 10 |
| 2024 Q1 | 112,818 | $219,125 | -$86,729 | $1.95 | 10 |
| 2023 Q4 | 160,652 | $231,338 | +$79,313 | $1.44 | 10 |
| 2023 Q3 | 105,573 | $175,734 | +$9,904 | $1.67 | 8 |
| 2023 Q2 | 99,698 | $203,640 | +$25,715 | $2.05 | 7 |
| 2023 Q1 | 87,154 | $183,307 | +$131,422 | $2.10 | 6 |
| 2022 Q4 | 21,483 | $72,276 | -$186,568 | $3.37 | 6 |
| 2022 Q3 | 50,673 | $273,000 | +$273,000 | $5.41 | 3 |